November 9, 2021 -- InvestorsHub NewsWire -- via pennymillions --

Pharmagreen Biotech, Inc. (PHBI) is on the verge of becoming the next big name in the cannabis sector.  The company has proprietary tissue culture technology it is applying to the cannabis sector to provide best in class marijuana and hemp plants to growers looking for consistent genetic quality.

The company is investing in its public platform in addition to its proprietary technology founded operation.  PHBI just announced its OTCBB application.

PHBI’s presence in the cannabis sector is growing and the company is on the verge of a technical breakout.  The PPS is hovering just around its $0.027 200 day moving average (MA) already above its 50 day moving average and the recent trading has just produced an MACD cross.  Volume is building.

The 52-week high is $0.09 with under 300 million shares in the float.  News could trigger momentum that drives the PPS from the current $0.027 back to $0.09 for a 3 X ROI.


 
SOURCE: pennymillions
Pharmagreen Biotech (PK) (USOTC:PHBI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Pharmagreen Biotech (PK).
Pharmagreen Biotech (PK) (USOTC:PHBI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Pharmagreen Biotech (PK).